Course Content
01. Anxiolytics and Sedative–Hypnotics: Clinical Map
You don't currently have access to this content
02. Anxiety: Neurobiology and Medical Mimics
You don't currently have access to this content
03. Insomnia: Symptom, Disorder, or Warning Sign?
You don't currently have access to this content
04. Dose-Dependent Central Nervous System Depression
You don't currently have access to this content
05. GABA-A Receptor: Molecular Brake System
You don't currently have access to this content
06. Major Drug Classes and Receptor Targets
You don't currently have access to this content
07. Benzodiazepines: Mechanism and Core Effects
You don't currently have access to this content
08. Benzodiazepine Prototypes: Choosing Rationally
You don't currently have access to this content
09. Benzodiazepine Pharmacokinetics and the LOT Rule
You don't currently have access to this content
10. Benzodiazepine Adverse Effects and Monitoring
You don't currently have access to this content
11. High-Risk Interactions and CNS Depressant Synergy
You don't currently have access to this content
12. Flumazenil: Benzodiazepine Antagonist
You don't currently have access to this content
13. Tolerance, Dependence, Withdrawal, and Tapering
You don't currently have access to this content
14. Barbiturates: Pharmacology, Uses, and Toxicity
You don't currently have access to this content
15. Z-Drugs: Zolpidem, Zaleplon, Eszopiclone
You don't currently have access to this content
16. Modern Insomnia Drugs Beyond Z-Drugs
You don't currently have access to this content
17. Buspirone: Non-Sedating Anxiolytic
You don't currently have access to this content
18. SSRIs and SNRIs in Anxiety Disorders
You don't currently have access to this content
19. Adjuncts: Hydroxyzine, Propranolol, Pregabalin
You don't currently have access to this content
20. Special Populations and High-Risk Patients
You don't currently have access to this content
21. Procedural Sedation: What Benzodiazepines Can and Cannot Do
You don't currently have access to this content
22. Clinical Selection by Scenario
You don't currently have access to this content
23. Nonpharmacologic Treatment and Patient Counseling
You don't currently have access to this content
24. Toxicity Recognition and Emergency Priorities
You don't currently have access to this content
25. Final Board-Ready Takeaways
You don't currently have access to this content

